Structured evidence table for Garlic Cognition Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Garlic Cognition Randomized Trial | The risk of bias of ten randomized controlled trials (RCTs) included in the meta-analysis was assessed using the Cochrane guidelines. | 1 | Deshmukh S (2025) | Effectiveness and safety of Ayurvedic intervention in essential hypertension: a systematic review with meta-analysis. |
| Garlic Cognition Randomized Trial | Result A total of 44 studies was included in the systematic review, and ten RCTs involving 524 participants were included in the meta-analysis. | 1 | Deshmukh S (2025) | Effectiveness and safety of Ayurvedic intervention in essential hypertension: a systematic review with meta-analysis. |
| Garlic Cognition Randomized Trial | Conclusion This systematic review shows that although Ayurvedic interventions do not achieve significant BP reductions versus conventional treatments, they may provide clinical benefits with good safety. | 1 | Deshmukh S (2025) | Effectiveness and safety of Ayurvedic intervention in essential hypertension: a systematic review with meta-analysis. |
| Garlic Cognition Randomized Trial | Background Essential hypertension (EH) is a major contributor to cardiovascular morbidity and mortality that has become a public health challenge owing to poor control and adherence. | 1 | Deshmukh S (2025) | Effectiveness and safety of Ayurvedic intervention in essential hypertension: a systematic review with meta-analysis. |
| Garlic Cognition Randomized Trial | These changes likely contribute to cognitive decline, sensorimotor impairments and increased vulnerability to neurodegenerative disorders (). | 4 | Mony Tamanna (2026) | Supplementation of aged garlic extract attenuates age-associated memory impairment and cognitive decline: Involvement of molecular pathways in the cortex and hippocampus |
| Garlic Cognition Randomized Trial | There is strong evidence indicating the ability of AGE to slow the progression of atherosclerosis, thus serving as a nutraceutical in the primary prevention and mitigation of CVD and stroke. | 4 | Mony Tamanna (2026) | Supplementation of aged garlic extract attenuates age-associated memory impairment and cognitive decline: Involvement of molecular pathways in the cortex and hippocampus |
| Garlic Cognition Randomized Trial | There is also evidence showing the ability of AGE to inhibit lipid peroxidation, reduce ischemic/reperfusion damage and inhibit oxidative modification of low-density lipoprotein (). | 4 | Mony Tamanna (2026) | Supplementation of aged garlic extract attenuates age-associated memory impairment and cognitive decline: Involvement of molecular pathways in the cortex and hippocampus |
| Garlic Cognition Randomized Trial | 1 2 3 4 5 6 7-9 10 The population of US citizens aged 65 years and older is projected to increase from 58 million in 2022 to 82 million by 2050(). | 4 | Mony Tamanna (2026) | Supplementation of aged garlic extract attenuates age-associated memory impairment and cognitive decline: Involvement of molecular pathways in the cortex and hippocampus |
Source documents